Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

4.000 +0.130 (+3.36%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,106,070
Open 3.900
Bid (Size) 4.000 (500)
Ask (Size) 4.010 (2,000)
Prev. Close 3.870
Today's Range 3.795 - 4.015
52wk Range 1.150 - 6.750
Shares Outstanding 166,010,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment ↗
GH001 showed symptom improvement, high remission rates, and sustained benefits in a Phase 2b trial for treatment-resistant depression. 
Via Stocktwits
News headline image
AtaiBeckley Completes Redomiciliation to the United States
From AtaiBeckley N.V.
Via GlobeNewswire

Performance

YTD
+3.4%
+3.4%
1 Month
-10.1%
-10.1%
3 Month
-26.9%
-26.9%
6 Month
+45.5%
+45.5%
1 Year
+124.7%
+124.7%

More News

Read More
News headline image
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
MarketBeat’s Top 5 Rated Small-Cap Stocks ↗
Via MarketBeat
News headline image
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
Via Stocktwits
Topics Cannabis ETFs Government
News headline image
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
Analyst Expectations For ATAI Life Sciences's Future ↗
Via Benzinga
News headline image
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
From atai Life Sciences
Via GlobeNewswire
News headline image
Why Atai Life Sciences Stock Was So Lively This Week ↗
Via The Motley Fool
News headline image
atai Life Sciences Announces Pricing of Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Announces Proposed Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
News headline image
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside ↗
Via Benzinga
News headline image
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews ↗
Via Benzinga
News headline image
Why Atai Life Sciences Stock Crushed It on Tuesday ↗
Via The Motley Fool
News headline image
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients ↗
Via Benzinga
News headline image
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225% ↗
Via Benzinga
Topics Artificial Intelligence

Frequently Asked Questions

Is AtaiBeckley Inc. - Common Stock publicly traded?
Yes, AtaiBeckley Inc. - Common Stock is publicly traded.
What exchange does AtaiBeckley Inc. - Common Stock trade on?
AtaiBeckley Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AtaiBeckley Inc. - Common Stock?
The ticker symbol for AtaiBeckley Inc. - Common Stock is ATAI on the Nasdaq Stock Market
What is the current price of AtaiBeckley Inc. - Common Stock?
The current price of AtaiBeckley Inc. - Common Stock is 4.000
When was AtaiBeckley Inc. - Common Stock last traded?
The last trade of AtaiBeckley Inc. - Common Stock was at 01/06/26 04:00 PM ET
What is the market capitalization of AtaiBeckley Inc. - Common Stock?
The market capitalization of AtaiBeckley Inc. - Common Stock is 664.04M
How many shares of AtaiBeckley Inc. - Common Stock are outstanding?
AtaiBeckley Inc. - Common Stock has 664M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.